{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:25:48Z","timestamp":1792009548819,"version":"4.4.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Vascular calcification (VC) is an active process, resulting from the disturbance of balance between inhibitors and promoters of calcification, in favor of the latter. Matrix Gla Protein, a powerful inhibitor of VC, needs vitamin K to become active. In vitamin K depletion, plasma levels of the inactive form of MGP, dephosphorylated, uncarboxylated MGP (dp-ucMGP) are increased and associated with VC and cardiovascular (CV) outcomes. End Stage Renal Disease (ESRD) patients have increased circulating dp-ucMGP levels and accelerated VC. VItamin K In PEritoneal DIAlysis (VIKIPEDIA) is a prospective, randomized, open label, placebo-controlled trial, evaluating the effect of vitamin K2 supplementation on arterial stiffness and CV events in ESRD patients undergoing peritoneal dialysis (PD). Forty-four PD patients will be included in the study. At baseline, dp-ucMGP and pulse-wave velocity (PWV) will be assessed and then patients will be randomized (1:1 ratio) to vitamin K (1000 \u03bcg MK-7\/day) or placebo for 1.5 years. The primary endpoint of this trial is the change in PWV in the placebo group as compared to the treatment group. Secondary endpoints are the occurrence of CV events, mortality, changes in PD adequacy, change in 24-hour ambulatory blood pressure indexes and aortic systolic blood pressure and changes in calcium\/phosphorus\/parathormone metabolism. VIKIPEDIA is a new superiority randomized, open label, placebo-controlled trial aiming to determine the effect of vitamin K2 supplementation on VC, CV disease and calcium\/phosphorus metabolism, in PD patients.<\/jats:p>\n<jats:p><jats:bold>Trial registration:<\/jats:bold> The protocol of this study is registered at ClinicalTrials.gov with identification number <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04900610\" xlink:type=\"simple\">NCT04900610<\/jats:ext-link> (25 May 2021).<\/jats:p>","DOI":"10.1371\/journal.pone.0273102","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T17:41:08Z","timestamp":1660758068000},"page":"e0273102","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9423-649X","authenticated-orcid":true,"given":"Stefanos","family":"Roumeliotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0314-9794","authenticated-orcid":true,"given":"Athanasios","family":"Roumeliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis I.","family":"Georgianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Thodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J.","family":"Schurgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Maresz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-1633","authenticated-orcid":true,"given":"Theodoros","family":"Eleftheriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Dounousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Liakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"issue":"6","key":"pone.0273102.ref001","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00041552-200211000-00010","article-title":"Prognostic significance of arterial stiffness measurements in end-stage renal disease patients","volume":"11","author":"J Blacher","year":"2002","journal-title":"Current opinion in nephrology and hypertension"},{"issue":"12","key":"pone.0273102.ref002","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1097\/HJH.0000000000002574","article-title":"A comparative study of ambulatory central hemodynamics and arterial stiffness parameters in peritoneal dialysis and hemodialysis patients","volume":"38","author":"M-E Alexandrou","year":"2020","journal-title":"Journal of Hypertension"},{"key":"pone.0273102.ref003","article-title":"Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomised, placebo-controlled RenaKvit trial","author":"K Levy-Schousboe","year":"2021","journal-title":"Clinical Kidney Journal"},{"key":"pone.0273102.ref004","doi-asserted-by":"crossref","first-page":"2054358120906974","DOI":"10.1177\/2054358120906974","article-title":"Pharmacologic therapies for aortic stiffness in end-stage renal disease: a systematic review and meta-analysis","volume":"7","author":"RA Rodriguez","year":"2020","journal-title":"Canadian journal of kidney health and disease"},{"issue":"6620","key":"pone.0273102.ref005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"G Luo","year":"1997","journal-title":"Nature"},{"key":"pone.0273102.ref006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.acc.2020.02.004","article-title":"Biomarkers of vascular calcification in serum","volume":"98","author":"S Roumeliotis","year":"2020","journal-title":"Advances in clinical chemistry"},{"key":"pone.0273102.ref007","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fmed.2020.00154","article-title":"Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein","volume":"7","author":"S Roumeliotis","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"pone.0273102.ref008","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood-2006-08-040709","article-title":"Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7","volume":"109","author":"LJ Schurgers","year":"2007","journal-title":"Blood"},{"issue":"3","key":"pone.0273102.ref009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030628","article-title":"Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review","volume":"20","author":"S Roumeliotis","year":"2019","journal-title":"Int J Mol Sci"},{"key":"pone.0273102.ref010","article-title":"Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients","author":"ME Fain","year":"2018","journal-title":"Am J Hypertens"},{"issue":"9","key":"pone.0273102.ref011","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/ajh\/hpy079","article-title":"Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness","volume":"31","author":"H Puzantian","year":"2018","journal-title":"Am J Hypertens"},{"issue":"12","key":"pone.0273102.ref012","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.ATV.0000245793.83158.06","article-title":"Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification","volume":"26","author":"CJ O\u2019Donnell","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"pone.0273102.ref013","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.07081009","article-title":"The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report","volume":"5","author":"LJ Schurgers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"17","key":"pone.0273102.ref014","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176035","article-title":"The Association of dp-ucMGP with Cardiovascular Morbidity and Decreased Renal Function in Diabetic Chronic Kidney Disease","volume":"21","author":"S Roumeliotis","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0273102.ref015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11255-019-02080-x","article-title":"Associations of vitamin K status with mortality and cardiovascular events in peritoneal dialysis patients","volume":"51","author":"Q Xu","year":"2019","journal-title":"International urology and nephrology"},{"key":"pone.0273102.ref016","article-title":"Vitamin K for the treatment of cardiovascular disease in End-Stage Renal Disease patients: is there hope?","author":"S Roumeliotis","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"key":"pone.0273102.ref017","first-page":"1","article-title":"Letter to the Editor regarding \u201cSix months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2\u201d","author":"S Roumeliotis","year":"2021","journal-title":"European Journal of Nutrition"},{"issue":"7","key":"pone.0273102.ref018","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ndt\/gft464","article-title":"Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study","volume":"29","author":"R Caluwe","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"pone.0273102.ref019","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","article-title":"Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial","volume":"59","author":"R Westenfeld","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"pone.0273102.ref020","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s11255-019-02275-2","article-title":"The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial","volume":"51","author":"T Oikonomaki","year":"2019","journal-title":"International urology and nephrology"},{"issue":"1","key":"pone.0273102.ref021","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12882-017-0609-3","article-title":"High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial","volume":"18","author":"M Aoun","year":"2017","journal-title":"BMC Nephrol"},{"key":"pone.0273102.ref022","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"A-W Chan","year":"2013","journal-title":"Bmj"},{"issue":"1","key":"pone.0273102.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28629-x","article-title":"Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study","volume":"8","author":"NH Leenders","year":"2018","journal-title":"Scientific Reports"},{"key":"pone.0273102.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"Bone metabolism and disease in chronic kidney disease","volume":"42","author":"G Eknoyan","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"113","key":"pone.0273102.ref025","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","author":"KDIGOC-MW Group","year":"2009","journal-title":"Kidney international Supplement"},{"issue":"36","key":"pone.0273102.ref026","article-title":"Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): a study protocol for a randomized controlled trial","volume":"99","author":"B-C Sabrina-Wong-Peixin Haroon","year":"2020","journal-title":"Medicine"},{"issue":"4","key":"pone.0273102.ref027","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1160\/TH09-11-0786","article-title":"Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species","volume":"104","author":"EC Cranenburg","year":"2010","journal-title":"Thromb Haemost"},{"issue":"10","key":"pone.0273102.ref028","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.3390\/nu13103490","article-title":"Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk","volume":"13","author":"N Rapp","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"pone.0273102.ref029","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15321819508013559","article-title":"Production of a new monoclonal antibody specific to human des-gamma-carboxyprothrombin in the presence of calcium ions. Application to the development of a sensitive ELISA-test","volume":"16","author":"M Belle","year":"1995","journal-title":"Journal of Immunoassay and Immunochemistry"},{"issue":"6","key":"pone.0273102.ref030","first-page":"298","article-title":"Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations","volume":"30","author":"LJ Schurgers","year":"2000","journal-title":"Haemostasis"},{"issue":"1","key":"pone.0273102.ref031","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2215\/CJN.03340807","article-title":"Vascular stiffness: its measurement and significance for epidemiologic and outcome studies","volume":"3","author":"SS DeLoach","year":"2008","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"21","key":"pone.0273102.ref032","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"S Laurent","year":"2006","journal-title":"European heart journal"},{"key":"pone.0273102.ref033","article-title":"Accuracy of a Newly-Introduced Oscillometric Device for the Estimation of Arterial Stiffness Indices in Patients on Peritoneal Dialysis: A Preliminary Validation Study","author":"V Vaios","year":"2018","journal-title":"Advances in peritoneal dialysis Conference on Peritoneal Dialysis;"},{"issue":"3","key":"pone.0273102.ref034","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYP.0000000000000033","article-title":"Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association","volume":"66","author":"RR Townsend","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"pone.0273102.ref035","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.119.13443","article-title":"Clinic and home blood pressure monitoring for the detection of ambulatory hypertension among patients on peritoneal dialysis","volume":"74","author":"V Vaios","year":"2019","journal-title":"Hypertension"},{"issue":"4","key":"pone.0273102.ref036","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/ije\/dyu080","article-title":"What is the difference between missing completely at random and missing at random?","volume":"43","author":"K Bhaskaran","year":"2014","journal-title":"International journal of epidemiology"},{"issue":"5","key":"pone.0273102.ref037","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1523-1755.2003.00932.x","article-title":"Aortic pulse wave velocity index and mortality in end-stage renal disease","volume":"63","author":"J Blacher","year":"2003","journal-title":"Kidney international"},{"issue":"2","key":"pone.0273102.ref038","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/ndt\/gfm470","article-title":"Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease","volume":"23","author":"M Frimodt-M\u00f8ller","year":"2008","journal-title":"Nephrology Dialysis Transplantation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0273102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T17:41:36Z","timestamp":1660758096000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0273102"}},"subtitle":[],"editor":[{"given":"Rogier","family":"Caluwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0273102","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]}}}